Cargando…
Over-prescription of short-acting β(2)-agonists remains a serious health concern in Kenya: results from the SABINA III study
BACKGROUND: Despite a high asthma burden in Kenya, insights into asthma management practices, including prescription of short-acting β(2)-agonists (SABAs), are lacking. Therefore, this study describes patient demographics, disease characteristics, and asthma treatment patterns in the Kenyan cohort o...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329295/ https://www.ncbi.nlm.nih.gov/pubmed/37422638 http://dx.doi.org/10.1186/s12875-023-02030-8 |